Q3 2018 Holdings
Filed 2018-11-14 | 56 holdings | $16.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bausch Health Cos Inc(BHC) | COM | 071734107 | $14.0M | 545,500 | 85.2% |
| Adaptimmune Therapeutics Plc(ADAPY) | SPONDS ADR | 00653A107 | $1.0M | 74,132 | 6.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $913.0K | 43,980 | 5.6% |
| Spdr S&P Biotech ETF(XBI)Put | S&P BIOTECH | 78464A870 | $95.9K | 1,000,000 | 0.6% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $30.7K | 1,735,030 | 0.2% |
| Allergan PLC | SHS | G0177J108 | $30.2K | 158,712 | 0.2% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $29.1K | 1,398,577 | 0.2% |
| BioMarin Pharmaceutical Inc(BMRN)Call | COM | 09061G101 | $29.1K | 300,000 | 0.2% |
| Mylan NV | SHS EURO | N59465109 | $25.5K | 695,788 | 0.2% |
| Dova Pharmaceuticals Inc(DOVA) | COM | 25985T102 | $21.5K | 1,026,906 | 0.1% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $21.4K | 541,172 | 0.1% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $20.9K | 549,231 | 0.1% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $17.7K | 737,303 | 0.1% |
| Endocyte Inc | COM | 29269A102 | $11.6K | 654,532 | 0.1% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $10.9K | 849,979 | 0.1% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $10.4K | 500,000 | 0.1% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $10.1K | 908,664 | 0.1% |
| ArQule Inc(ARQLUSD) | COM | 04269E107 | $9.8K | 1,737,397 | 0.1% |
| Stemline Therapeutics Inc | COM | 85858C107 | $9.7K | 582,070 | 0.1% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $9.6K | 892,579 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $9.4K | 464,159 | 0.1% |
| TherapeuticsMD Inc | COM | 88338N107 | $8.6K | 1,307,100 | 0.1% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $7.8K | 128,000 | 0.0% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $7.6K | 193,279 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $5.8K | 1,583,954 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.7K | 327,730 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $5.5K | 311,536 | 0.0% |
| Eli Lilly & Co(LLY)Put | COM | 532457108 | $5.4K | 50,000 | 0.0% |
| Pfizer Inc(PFE)Put | COM | 717081103 | $5.3K | 120,000 | 0.0% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $5.1K | 250,000 | 0.0% |
| Foamix Pharmaceuticals Ltd | SHS | M46135105 | $4.3K | 747,308 | 0.0% |
| Zosano Pharma Corp | COM NEW | 98979H202 | $4.2K | 1,033,759 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $3.5K | 231,613 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $3.3K | 296,500 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $3.1K | 50,414 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $2.8K | 89,849 | 0.0% |
| Sesen Bio Inc | COM | 817763105 | $2.5K | 1,177,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.5K | 445,000 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $2.3K | 636,646 | 0.0% |
| OncoSec Medical Inc | COM NEW | 68234L207 | $1.9K | 1,388,824 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $1.8K | 150,000 | 0.0% |
| Neos Therapeutics Inc(NEOS) | COM | 64052L106 | $1.5K | 311,502 | 0.0% |
| OncoMed Pharmaceuticals Inc | COM | 68234X102 | $1.3K | 634,715 | 0.0% |
| Synergy Pharmaceuticals Inc | COM NEW | 871639308 | $1.3K | 746,200 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $1.2K | 30,622 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $1.1K | 181,011 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $1.1K | 97,600 | 0.0% |
| MediWound Ltd | ORD SHS | M68830104 | $1.1K | 173,076 | 0.0% |
| ProQR Therapeutics NV | SHS EURO | N71542109 | $1.0K | 52,875 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $983 | 50,000 | 0.0% |